Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > April 29, Next Monday expecting an annual report, will see

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Apr 25, 2024 6:07pm

142 Views

Post# 36008211

RE:RE:RE:RE:RE:RE:RE:April 29, Next Monday expecting an annual report, will see

FDA approval was already baked in for IBRX, IMHO. Market Cap is at $3.72 Billion USD. 100 times more than ours. Like us being at 15-18$ US

Alamir1111 wrote: Ibrx in 2 days of trading after receiving btd gained approximately 10%

$5.16

0.3399 |

7.05%

Bid: 5.15 x 2,600 Ask: 5.16 x 500 Volume: 7,014,310

USD | NDAQ | DELAYED | | APRIL 25, 2024 03:28:00 PM EDT